GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
![](https://catedrasaludrespiratoria.com/wp-content/uploads/2023/06/GOLD-COPD-DOCUMENT-2023-a-brief-update-for-practicing-cardiologists.jpg)
COPD is the elephant in the room for many patients with CVDs. It is a prevalent, preventable, and treatable condition, but most often it has not been diagnosed and, hence, not treated appropriately [2]. Importantly for cardiology practice, optimal management of COPD is associated with improved cardiovascular outcomes [66]. Yet, such clinical management requires, to begin with, a high level of suspicion and appropriate confirmation of diagnosis by spirometry. Initial treatment should focus on smoking abstinence and use of one or two long-acting bronchodilators. Referral to specialized pulmonary care is advised if response to treatment is not satisfactory.
Puedes leer el artículo completo aquí: https://link.springer.com/article/10.1007/s00392-023-02217-0
Noticias relacionadas
![DNA Methylation in COPD](https://catedrasaludrespiratoria.com/wp-content/uploads/2024/07/dna-methylation-in-copd-v2-300x225.webp)
Is the association between the severity of airflow limitation and DNA Methylation similar in blood and lung tissue in patients with COPD?
The relationship between airflow limitation severity and DNA methylation in COPD patients. Findings reveal CpGs with opposite associations in blood and lung tissues, highlighting distinct regulatory mechanisms.
![Treatable traits in pre-COPD](https://catedrasaludrespiratoria.com/wp-content/uploads/2024/07/Treatable-traits-in-pre-COPD-300x225.webp)
Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease
Explore how the treatable traits approach can be applied to pre-COPD, potentially preventing full disease development. Learn about GETomics and its role in understanding pre-COPD through gene-environment interactions.
![Epigenetic Age Acceleration in COPD Blood vs. Lung Tissue](https://catedrasaludrespiratoria.com/wp-content/uploads/2024/07/Epigenetic-Age-Acceleration-in-COPD-Blood-vs-Lung-Tissue-300x225.webp)
Epigenetic age acceleration and severity of airflow limitation on blood and lung tissue of COPD
Discover the distinct patterns of epigenetic age acceleration in COPD patients. Our study reveals significant associations between airflow limitation severity and biological age in blood, highlighting different aging biomarkers in lung tissue.
Más artículos
EPOC
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768778·Alvar Agusti, Claus F. Vogelmeier – GOLD 2024: a brief overview of key changes
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
- 769092·Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en el artículo original.